IP Library Granted Patent US 10,208,092
Granted Patent B2
US 10,208,092 · App. 15/526,895 · Granted Feb 19, 2019

Modified kappa light chain-binding polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,208,092
App. No.
15/526,895
Granted
Feb 19, 2019
Kind
B2
Abstract

The invention discloses kappa light chain-binding polypeptide comprising a mutated binding domain of Peptostreptococcus protein L, wherein at least one asparagine residue of a parental domain defined by, or having at least 95% or 98% sequence homology with, SEQ ID NO: 2-6 or 2 has been mutated to another amino acid residue which is not asparagine, proline or cysteine.

Claims (25)

1. A kappa light chain-binding polypeptide comprising at least one mutated binding domain of Peptostreptococcus Protein L, in which the domain has been mutated at positions:

N45A and comprising the amino acid sequence defined by SEQ ID NO: 7;

N10Q,N45A and comprising the amino acid sequence defined by SEQ ID NO: 8;

N45A,N60Q and comprising the amino acid sequence defined by SEQ ID NO: 9; or

N10Q,N45A,N60Q and comprising the amino acid sequence defined by SEQ ID NO: 11.

2. The polypeptide of claim 1 , in which the domain has been mutated at position N45A and comprising the amino acid sequence defined by SEQ ID NO: 7.

3. The polypeptide of claim 1 , in which the domain has been mutated at positions N10Q,N45A and comprising the amino acid sequence defined by SEQ ID NO: 8.

4. The polypeptide of claim 1 , in which the domain has been mutated at positions N45A,N60Q and comprising the amino acid sequence defined by SEQ ID NO: 9.

5. The polypeptide of claim 1 , in which the domain has been mutated at positions N10Q,N45A,N60Q and comprising the amino acid sequence defined by SEQ ID NO: 11.

6. The polypeptide of claim 1 , comprising a plurality of domains wherein the domains are linked by elements comprising up to 15 amino acids.

7. The polypeptide according to claim 1 , wherein the alkaline stability is improved relative to a parental polypeptide, as measured by the remaining binding capacity for kappa light chain-containing proteins after 96-100 10 min incubation cycles in 0.1M aqueous NaOH at 22+/−2° C.

8. A nucleic acid or a vector encoding a polypeptide according to claim 1 .

9. An expression system, which comprises a nucleic acid or vector according to claim 8 .

10. A separation matrix, wherein a plurality of polypeptides of claim 1 have been coupled to a solid support.

11. The separation matrix according to claim 10 , wherein the polypeptides have been coupled to the solid support by multipoint attachment.

12. The separation matrix of claim 10 , wherein the binding capacity of the matrix for kappa light chain-containing proteins after 100 10 min incubation cycles in 0.1M NaOH at 22+/−2° C. is at least 40, such as at least 50, or at least 55% of the binding capacity before the incubation.

13. A method of isolating a kappa light chain-containing protein, comprising isolating the kappa light chain-containing protein with the separation matrix of claim 10 .

14. A method of isolating a kappa light chain-containing protein comprising the steps of:

a) contacting a liquid sample comprising a kappa light chain-containing protein with a separation matrix of claim 10 ,

b) washing said separation matrix with a washing liquid,

c) eluting the kappa light chain-containing protein from the separation matrix with an elution liquid, and

d) cleaning the separation matrix with a cleaning liquid.

15. The method of claim 14 , wherein the cleaning liquid is alkaline, such as with a pH of 12-14.

16. The method of claim 14 , wherein the cleaning liquid comprises 0.01-1.0M NaOH or KOH, such as 0.05-1.0M or 0.05-0.1M NaOH or KOH.

17. The method of claim 14 , wherein steps a)-d) are repeated at least 10 times, such as at least 50 times or 50-200 times.

Assignments (3)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2017
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 042910/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2017
From: RODRIGO, GUSTAV; BJORKMAN, TOMAS; ANDER, MATS
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 042380/0473 →